TOP TIERMARKET NEWSWIRE
News & sentiment

GOSSAMER BIO INC (GOSS) — News & AI sentiment

GOSSAMER BIO INC (GOSS) news roundup. 1 story in the past week, 4 over 30 days. Average 30-day sentiment is 56.5/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 50/100
30d stories
4
avg sentiment 56.5/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

GOSS news in the last 24 hours, 7 days, 30 days and 90 days

How much GOSS coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowGOSS storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days150/100GOSS headlines →
Last 30 days456.5/100GOSS headlines →
Last 90 days3645.7/100GOSS headlines →

Latest stories on GOSS

Chardan reiterates Gossamer Bio stock rating on PAH drug outlook
Investing.com Analyst Ratings50 · neutralanalyst
2d ago
Oct 13
Chardan initiates Gossamer Bio stock with buy on PAH therapy potential
Investing.com Analyst Ratings63 · neutralanalyst
Oct 13
Gossamer Bio, Inc. (GOSS) files 8-K
SEC 8-K50 · neutralgeneral
Sep 28
Sep 23
Sep 23
Gossamer Bio, Inc. (GOSS) files 8-K
SEC 8-K50 · neutralgeneral
Sep 23
Sep 23
Sep 21
Gossamer Bio, Inc. (GOSS) files 8-K
SEC 8-K50 · neutralgeneral
Sep 16
Sep 16
Sep 11
Gossamer Bio, Inc. (GOSS) files 8-K
SEC 8-K50 · neutralgeneral
Sep 11
Sep 11
Sep 10
Gossamer Bio, Inc. (GOSS) files 8-K
SEC 8-K50 · neutralgeneral
Sep 9
Sep 9
Sep 8
Sep 4
Gossamer Bio, Inc. (GOSS) files 8-K
SEC 8-K50 · neutralgeneral
Sep 3
Aug 27
H.C. Wainwright reiterates Gossamer Bio stock rating on NDA progress
Investing.com Analyst Ratings56 · neutralanalyst
Aug 27
Gossamer Bio, Inc. (GOSS) files 8-K
SEC 8-K50 · neutralgeneral
Aug 26
Aug 24
Aug 21
Open GOSS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →